Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Coagulation Disorders | 2 | 2020 | 104 | 1.120 |
Why?
|
| Hemorrhagic Disorders | 4 | 2022 | 24 | 1.100 |
Why?
|
| Menorrhagia | 4 | 2022 | 77 | 1.070 |
Why?
|
| Pathologists | 1 | 2021 | 27 | 0.700 |
Why?
|
| Gastritis | 2 | 2021 | 371 | 0.700 |
Why?
|
| Telerehabilitation | 1 | 2020 | 8 | 0.660 |
Why?
|
| Hematology | 1 | 2020 | 42 | 0.630 |
Why?
|
| von Willebrand Diseases | 4 | 2022 | 55 | 0.630 |
Why?
|
| Factor V Deficiency | 1 | 2019 | 2 | 0.610 |
Why?
|
| alpha-2-Antiplasmin | 1 | 2019 | 4 | 0.610 |
Why?
|
| Fibrinolysis | 1 | 2019 | 42 | 0.600 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2019 | 49 | 0.600 |
Why?
|
| Autoimmune Diseases | 1 | 2021 | 264 | 0.590 |
Why?
|
| Gastric Mucosa | 2 | 2021 | 492 | 0.590 |
Why?
|
| Tranexamic Acid | 1 | 2019 | 31 | 0.590 |
Why?
|
| Antifibrinolytic Agents | 1 | 2019 | 47 | 0.580 |
Why?
|
| Stress, Psychological | 1 | 2020 | 544 | 0.460 |
Why?
|
| Caregivers | 1 | 2020 | 572 | 0.430 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2020 | 622 | 0.420 |
Why?
|
| Neuroendocrine Tumors | 2 | 2025 | 69 | 0.420 |
Why?
|
| Anxiety | 1 | 2020 | 1001 | 0.400 |
Why?
|
| Parents | 1 | 2020 | 1102 | 0.390 |
Why?
|
| Depression | 1 | 2020 | 1315 | 0.350 |
Why?
|
| Precancerous Conditions | 2 | 2025 | 280 | 0.290 |
Why?
|
| Hemorrhage | 3 | 2022 | 492 | 0.270 |
Why?
|
| Blood Preservation | 2 | 2019 | 29 | 0.260 |
Why?
|
| Fatty Liver | 2 | 2025 | 221 | 0.240 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 2 | 2022 | 409 | 0.240 |
Why?
|
| Liver Cirrhosis | 2 | 2025 | 910 | 0.230 |
Why?
|
| Anus Neoplasms | 1 | 2025 | 42 | 0.230 |
Why?
|
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 1 | 2025 | 38 | 0.230 |
Why?
|
| von Willebrand Factor | 3 | 2022 | 190 | 0.220 |
Why?
|
| Bile Ducts, Extrahepatic | 1 | 2024 | 20 | 0.220 |
Why?
|
| Pancreas | 1 | 2025 | 222 | 0.210 |
Why?
|
| Urea Cycle Disorders, Inborn | 1 | 2025 | 84 | 0.210 |
Why?
|
| Parietal Cells, Gastric | 1 | 2024 | 38 | 0.210 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2025 | 188 | 0.200 |
Why?
|
| Humans | 26 | 2025 | 130372 | 0.190 |
Why?
|
| Papillomavirus Infections | 1 | 2025 | 383 | 0.170 |
Why?
|
| Erythrocytes | 2 | 2019 | 187 | 0.170 |
Why?
|
| Cryptosporidiosis | 1 | 2021 | 34 | 0.160 |
Why?
|
| Neoplasms, Complex and Mixed | 1 | 2020 | 6 | 0.160 |
Why?
|
| Sex Cord-Gonadal Stromal Tumors | 1 | 2020 | 11 | 0.160 |
Why?
|
| Receptors, Estrogen | 1 | 2024 | 726 | 0.160 |
Why?
|
| Health Care Surveys | 1 | 2021 | 277 | 0.160 |
Why?
|
| Granulosa Cell Tumor | 1 | 2020 | 38 | 0.160 |
Why?
|
| Point-of-Care Testing | 1 | 2020 | 31 | 0.160 |
Why?
|
| India | 1 | 2020 | 243 | 0.160 |
Why?
|
| Home Care Services | 1 | 2020 | 66 | 0.160 |
Why?
|
| Income | 1 | 2020 | 137 | 0.160 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2025 | 753 | 0.150 |
Why?
|
| Female | 18 | 2025 | 70274 | 0.150 |
Why?
|
| Blood Platelets | 2 | 2019 | 316 | 0.150 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2019 | 32 | 0.150 |
Why?
|
| Pancreatic Neoplasms | 1 | 2025 | 742 | 0.150 |
Why?
|
| Workload | 1 | 2020 | 149 | 0.150 |
Why?
|
| Cerebral Palsy | 1 | 2020 | 86 | 0.150 |
Why?
|
| Stem Cells | 1 | 2024 | 713 | 0.150 |
Why?
|
| Attitude to Health | 1 | 2020 | 244 | 0.150 |
Why?
|
| Tissue Array Analysis | 1 | 2019 | 135 | 0.150 |
Why?
|
| Microfluidics | 1 | 2019 | 30 | 0.150 |
Why?
|
| Postpartum Hemorrhage | 1 | 2020 | 109 | 0.150 |
Why?
|
| Diagnostic Errors | 2 | 2020 | 345 | 0.150 |
Why?
|
| Diethylnitrosamine | 1 | 2018 | 20 | 0.140 |
Why?
|
| Solitary Fibrous Tumors | 1 | 2018 | 8 | 0.140 |
Why?
|
| Phenobarbital | 1 | 2018 | 30 | 0.140 |
Why?
|
| Prospective Studies | 4 | 2025 | 6421 | 0.140 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2018 | 65 | 0.140 |
Why?
|
| Plasma | 1 | 2019 | 103 | 0.140 |
Why?
|
| Thrombelastography | 1 | 2019 | 66 | 0.140 |
Why?
|
| Blood Coagulation | 1 | 2019 | 134 | 0.140 |
Why?
|
| Erythrocyte Transfusion | 2 | 2019 | 141 | 0.140 |
Why?
|
| Inheritance Patterns | 1 | 2018 | 129 | 0.140 |
Why?
|
| Thyroid Gland | 1 | 2018 | 98 | 0.140 |
Why?
|
| Feeding Behavior | 1 | 2023 | 705 | 0.140 |
Why?
|
| Anemia | 1 | 2022 | 351 | 0.140 |
Why?
|
| Ovary | 1 | 2020 | 351 | 0.140 |
Why?
|
| Prevalence | 2 | 2025 | 2684 | 0.130 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2020 | 243 | 0.130 |
Why?
|
| Esophageal Mucosa | 1 | 2017 | 11 | 0.130 |
Why?
|
| Down Syndrome | 1 | 2020 | 234 | 0.130 |
Why?
|
| Liver | 1 | 2025 | 1797 | 0.130 |
Why?
|
| Mental Health | 1 | 2020 | 368 | 0.130 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2017 | 66 | 0.130 |
Why?
|
| Spinal Dysraphism | 1 | 2020 | 277 | 0.120 |
Why?
|
| Cell Differentiation | 1 | 2024 | 1929 | 0.120 |
Why?
|
| Ovarian Neoplasms | 1 | 2020 | 434 | 0.120 |
Why?
|
| Esophagoscopy | 1 | 2017 | 173 | 0.120 |
Why?
|
| Metabolome | 1 | 2019 | 325 | 0.120 |
Why?
|
| Microscopy, Confocal | 1 | 2017 | 340 | 0.120 |
Why?
|
| Colonic Polyps | 1 | 2017 | 81 | 0.120 |
Why?
|
| Blood Transfusion, Autologous | 1 | 2015 | 36 | 0.120 |
Why?
|
| Thyroid Neoplasms | 1 | 2018 | 249 | 0.120 |
Why?
|
| Hemolysis | 1 | 2015 | 87 | 0.110 |
Why?
|
| Developmental Disabilities | 1 | 2020 | 773 | 0.110 |
Why?
|
| Severity of Illness Index | 1 | 2023 | 3031 | 0.110 |
Why?
|
| Autism Spectrum Disorder | 1 | 2020 | 445 | 0.110 |
Why?
|
| Colonoscopy | 1 | 2017 | 241 | 0.110 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 262 | 0.110 |
Why?
|
| Adolescent | 6 | 2025 | 20747 | 0.100 |
Why?
|
| Age Factors | 1 | 2020 | 2835 | 0.100 |
Why?
|
| Child | 4 | 2025 | 26160 | 0.100 |
Why?
|
| Barrett Esophagus | 1 | 2017 | 360 | 0.100 |
Why?
|
| Adult | 10 | 2025 | 31117 | 0.100 |
Why?
|
| Esophageal Neoplasms | 1 | 2017 | 392 | 0.100 |
Why?
|
| Nitric Oxide | 1 | 2015 | 466 | 0.090 |
Why?
|
| Middle Aged | 8 | 2025 | 28370 | 0.090 |
Why?
|
| Helicobacter pylori | 1 | 2021 | 1362 | 0.090 |
Why?
|
| Endothelial Cells | 1 | 2015 | 520 | 0.090 |
Why?
|
| Helicobacter Infections | 1 | 2021 | 1302 | 0.090 |
Why?
|
| Male | 9 | 2025 | 64517 | 0.090 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 987 | 0.080 |
Why?
|
| Child, Preschool | 2 | 2025 | 14984 | 0.070 |
Why?
|
| Healthy Volunteers | 2 | 2019 | 150 | 0.070 |
Why?
|
| Biopsy | 2 | 2025 | 1237 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 4664 | 0.070 |
Why?
|
| Diet | 2 | 2023 | 1097 | 0.060 |
Why?
|
| Cystadenoma, Serous | 1 | 2025 | 15 | 0.060 |
Why?
|
| Formaldehyde | 1 | 2025 | 50 | 0.060 |
Why?
|
| Argininosuccinic Aciduria | 1 | 2025 | 53 | 0.060 |
Why?
|
| Gastric Acid | 1 | 2024 | 55 | 0.050 |
Why?
|
| Fast Foods | 1 | 2023 | 25 | 0.050 |
Why?
|
| Bile Duct Neoplasms | 1 | 2024 | 134 | 0.050 |
Why?
|
| Cluster Analysis | 1 | 2023 | 417 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2024 | 346 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 2918 | 0.050 |
Why?
|
| Early Detection of Cancer | 1 | 2025 | 416 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2025 | 1451 | 0.040 |
Why?
|
| Metaplasia | 1 | 2021 | 216 | 0.040 |
Why?
|
| Salpingo-oophorectomy | 1 | 2020 | 10 | 0.040 |
Why?
|
| Forkhead Box Protein L2 | 1 | 2020 | 10 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2025 | 17606 | 0.040 |
Why?
|
| von Willebrand Disease, Type 2 | 1 | 2019 | 4 | 0.040 |
Why?
|
| Plasticizers | 1 | 2019 | 2 | 0.040 |
Why?
|
| Oxidants | 1 | 2019 | 25 | 0.040 |
Why?
|
| Health Behavior | 1 | 2022 | 388 | 0.040 |
Why?
|
| Swine, Miniature | 1 | 2018 | 53 | 0.040 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2019 | 95 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 1 | 2018 | 65 | 0.040 |
Why?
|
| Diarrhea | 1 | 2021 | 311 | 0.040 |
Why?
|
| Immunocompromised Host | 1 | 2021 | 312 | 0.040 |
Why?
|
| Hysterectomy | 1 | 2020 | 199 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2019 | 261 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2020 | 789 | 0.040 |
Why?
|
| Stress, Mechanical | 1 | 2019 | 177 | 0.040 |
Why?
|
| Carcinogens | 1 | 2018 | 129 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2018 | 235 | 0.030 |
Why?
|
| Vasoconstrictor Agents | 1 | 2019 | 137 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 228 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 2019 | 187 | 0.030 |
Why?
|
| Time Factors | 2 | 2019 | 6186 | 0.030 |
Why?
|
| Feces | 1 | 2021 | 721 | 0.030 |
Why?
|
| Exome | 1 | 2022 | 1075 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2019 | 276 | 0.030 |
Why?
|
| Aged | 2 | 2025 | 20883 | 0.030 |
Why?
|
| Observer Variation | 1 | 2017 | 312 | 0.030 |
Why?
|
| Liver Transplantation | 1 | 2025 | 1135 | 0.030 |
Why?
|
| Exercise | 1 | 2022 | 858 | 0.030 |
Why?
|
| Plethysmography | 1 | 2015 | 34 | 0.030 |
Why?
|
| Pennsylvania | 1 | 2015 | 60 | 0.030 |
Why?
|
| Acetylcholine | 1 | 2015 | 73 | 0.030 |
Why?
|
| Swine | 1 | 2018 | 1184 | 0.030 |
Why?
|
| Vasodilation | 1 | 2015 | 175 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 3800 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 1300 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2023 | 4001 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 2297 | 0.020 |
Why?
|
| Young Adult | 1 | 2025 | 9989 | 0.020 |
Why?
|
| Biomarkers | 1 | 2020 | 3393 | 0.020 |
Why?
|
| Animals | 2 | 2024 | 33924 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2019 | 5069 | 0.020 |
Why?
|
| Risk Factors | 1 | 2023 | 10937 | 0.020 |
Why?
|
| Pregnancy | 1 | 2020 | 7381 | 0.020 |
Why?
|
| Mice | 1 | 2024 | 18213 | 0.020 |
Why?
|
| Mutation | 1 | 2020 | 6131 | 0.020 |
Why?
|